These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28953679)

  • 21. A Case of Neuroleptic Malignant Syndrome in the Context of Lithium Toxicity and Aripiprazole Use.
    Schultz AR; Singh S; Linek-Rajapaksha CE; Goode HR; Fusick AJ
    Clin Neuropharmacol; 2024 Jan-Feb 01; 47(1):22-25. PubMed ID: 37874611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atypical Presentation of Ziprasidone-Induced Neuroleptic Malignant Syndrome: A Case Report.
    Allonce J; Khan S; Pulford B
    J Investig Med High Impact Case Rep; 2024; 12():23247096241262690. PubMed ID: 39044558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Neuroleptic malignant syndrome : Rare cause of fever of unknown origin].
    Chackupurakal R; Wild U; Kamm M; Wappler F; Reske D; Sakka SG
    Anaesthesist; 2015 Jul; 64(7):527-31. PubMed ID: 26122200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversible magnetic resonance imaging changes in a case of neuroleptic malignant syndrome.
    Jain RS; Gupta PK; Gupta ID; Agrawal R; Kumar S; Tejwani S
    Am J Emerg Med; 2015 Aug; 33(8):1113.e1-3. PubMed ID: 25769796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroleptic malignant syndrome with abnormally elevated cardiac troponin I: a case report.
    Wang Q; Shi J; Zhao P; Cao Q; Yao Z
    J Int Med Res; 2020 Nov; 48(11):300060520968344. PubMed ID: 33203271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroleptic malignant syndrome due to olanzapine.
    Hall KL; Taylor WH; Ware MR
    Psychopharmacol Bull; 2001; 35(3):49-54. PubMed ID: 12397878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neuroleptic malignant syndrome: case report with recurrence associated with the use of olanzapine].
    Hanel RA; Sandmann MC; Kranich M; De Bittencourt PR
    Arq Neuropsiquiatr; 1998 Dec; 56(4):833-7. PubMed ID: 10029891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The neuroleptic malignant syndrome (NMS). A report of a clinical case with a protracted and recurrent course. A review of the literature].
    Marelli A; Bodini P; Dizioli P; Chiodelli G; Guarneri M; Boldori L
    Minerva Med; 1996; 87(1-2):45-51. PubMed ID: 8610025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Catatonia and neuroleptic malignant syndrome: two disorders on a same spectrum? Three case reports].
    Luchini F; Lattanzi L; Bartolommei N; Cosentino L; Casamassima F; Litta A; Mauri M; Cassano GB
    Riv Psichiatr; 2012; 47(2):178-85. PubMed ID: 22622253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroleptic malignant syndrome and clozapine.
    Reddig S; Minnema AM; Tandon R
    Ann Clin Psychiatry; 1993 Mar; 5(1):25-7. PubMed ID: 8102300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probable case of neuroleptic malignant syndrome following administration of antituberculotic drugs in a chlorpromazine-treated patient.
    Shim G; Kang DH; Kwon JS
    J Korean Med Sci; 2008 Aug; 23(4):734-6. PubMed ID: 18756068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atypical Neuroleptic Malignant Syndrome: Diagnosis and Proposal for an Expanded Treatment Algorithm: A Case Report.
    Schreiner NM; Windham S; Barker A
    A A Case Rep; 2017 Dec; 9(12):339-343. PubMed ID: 28767476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroleptic malignant syndrome.
    McHugh TP
    J S C Med Assoc; 1992 Jun; 88(6):303-6. PubMed ID: 1352559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clozapine-associated neuroleptic malignant syndrome followed by catatonia: a case report].
    Erol A; Putgül G; Sert E; Mete L
    Turk Psikiyatri Derg; 2013; 24(2):140-4. PubMed ID: 23754268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atypical neuroleptic malignant syndrome caused by olanzapine.
    Nielsen J; Bruhn AM
    Acta Psychiatr Scand; 2005 Sep; 112(3):238-40; discussion 240. PubMed ID: 16095481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ziprasidone- and lithium-induced neuroleptic malignant syndrome.
    Borovicka MC; Bond LC; Gaughan KM
    Ann Pharmacother; 2006 Jan; 40(1):139-42. PubMed ID: 16352776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroleptic Malignant Syndrome: A Potential Etiology of Multisystem Organ Failure in a Burn Patient.
    Ficarino HM; Caposole MZ; Noelle Davis S; N Krebsbach M; McGowin EF; Alexander KM; Kinnard CM; Simmons JD
    Am Surg; 2022 Mar; 88(3):519-520. PubMed ID: 32988244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroleptic malignant syndrome after neuroleptic discontinuation.
    Amore M; Zazzeri N
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Dec; 19(8):1323-34. PubMed ID: 8868212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The application of electroconvulsive therapy in neuroleptic malignant syndrome treatment in patient with catatonic schizophrenia].
    Kucia K; Warchala A
    Wiad Lek; 2005; 58(9-10):572-4. PubMed ID: 16529073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroleptic malignant syndrome during abrupt reduction of neuroleptic treatment.
    Spivak B; Weizman A; Wolovick L; Hermesh H; Tyano S; Munitz H
    Acta Psychiatr Scand; 1990 Feb; 81(2):168-9. PubMed ID: 1970216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.